Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) 80% at baseline to 14.1% at 2-year
follow-up (FAS). The proportion of FAS patients needing hemolysis
Gilyazova, Irina,
Enikeeva, Kadriia,
Rafikova, Guzel,
Kagirova, Evelina,
Sharifyanova, Yuliya,
Asadullina, Dilara,
Pavlov, Valentin (2023) serve as noninvasive biomarkers, particularly useful for early cancer detection,
follow-up of patients